NEW YORK (GenomeWeb) – CareDx announced today that Allenex shareholders representing about 98 percent of the company's shares have accepted CareDx's takeover offer, and that it expects to close the deal on or around April 13.

CareDx acquired a 78 percent majority stake in the Swedish transplant diagnostics firm in December 2015. At the time, the firm also said that it planned to buy the remaining shares in the first quarter of 2016.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.